Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

A nine-long non-coding RNA signature for prognosis prediction of patients with lung squamous cell carcinoma.

Huang G, Huang Q, Xie Z, Zhou H, Cao J, Shi L, Yang M.

Cancer Biomark. 2019 Sep 6. doi: 10.3233/CBM-182275. [Epub ahead of print]

PMID:
31524143
2.

Integrated analysis of competing endogenous RNA network revealing lncRNAs as potential prognostic biomarkers in human lung squamous cell carcinoma.

Sui J, Xu SY, Han J, Yang SR, Li CY, Yin LH, Pu YP, Liang GY.

Oncotarget. 2017 Jul 27;8(39):65997-66018. doi: 10.18632/oncotarget.19627. eCollection 2017 Sep 12.

3.

Identification of a RNA-Seq based prognostic signature with five lncRNAs for lung squamous cell carcinoma.

Tang RX, Chen WJ, He RQ, Zeng JH, Liang L, Li SK, Ma J, Luo DZ, Chen G.

Oncotarget. 2017 Apr 13;8(31):50761-50773. doi: 10.18632/oncotarget.17098. eCollection 2017 Aug 1.

4.

Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.

Zhao QJ, Zhang J, Xu L, Liu FF.

World J Gastroenterol. 2018 Aug 14;24(30):3426-3439. doi: 10.3748/wjg.v24.i30.3426.

5.

Identification of lncRNA biomarkers in lung squamous cell carcinoma using comprehensive analysis of lncRNA mediated ceRNA network.

Li R, Yang YE, Jin J, Zhang MY, Liu X, Liu XX, Yin YH, Qu YQ.

Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):3246-3258. doi: 10.1080/21691401.2019.1647225.

PMID:
31364871
6.

A three-lncRNA signature predicts overall survival and disease-free survival in patients with esophageal squamous cell carcinoma.

Huang GW, Xue YJ, Wu ZY, Xu XE, Wu JY, Cao HH, Zhu Y, He JZ, Li CQ, Li EM, Xu LY.

BMC Cancer. 2018 Feb 6;18(1):147. doi: 10.1186/s12885-018-4058-6.

7.

A three-lncRNA expression signature predicts survival in head and neck squamous cell carcinoma (HNSCC).

Wang P, Jin M, Sun CH, Yang L, Li YS, Wang X, Sun YN, Tian LL, Liu M.

Biosci Rep. 2018 Nov 20;38(6). pii: BSR20181528. doi: 10.1042/BSR20181528. Print 2018 Dec 21.

8.

Identification of a novel four-lncRNA signature as a prognostic indicator in cirrhotic hepatocellular carcinoma.

Ma L, Deng C.

PeerJ. 2019 Aug 1;7:e7413. doi: 10.7717/peerj.7413. eCollection 2019.

9.

Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.

Gu JX, Zhang X, Miao RC, Xiang XH, Fu YN, Zhang JY, Liu C, Qu K.

World J Gastroenterol. 2019 Jan 14;25(2):220-232. doi: 10.3748/wjg.v25.i2.220.

10.

A novel seven-lncRNA signature for prognosis prediction in hepatocellular carcinoma.

Yan J, Zhou C, Guo K, Li Q, Wang Z.

J Cell Biochem. 2019 Jan;120(1):213-223. doi: 10.1002/jcb.27321. Epub 2018 Sep 11.

PMID:
30206981
11.

LncRNAs KB-1836B5, LINC00566 and FAM27L are associated with the survival time of patients with ovarian cancer.

Li H, Gong M, Zhao M, Wang X, Cheng W, Xia Y.

Oncol Lett. 2018 Sep;16(3):3735-3745. doi: 10.3892/ol.2018.9143. Epub 2018 Jul 12.

12.

LncRNA profile study reveals a three-lncRNA signature associated with the survival of patients with oesophageal squamous cell carcinoma.

Li J, Chen Z, Tian L, Zhou C, He MY, Gao Y, Wang S, Zhou F, Shi S, Feng X, Sun N, Liu Z, Skogerboe G, Dong J, Yao R, Zhao Y, Sun J, Zhang B, Yu Y, Shi X, Luo M, Shao K, Li N, Qiu B, Tan F, Chen R, He J.

Gut. 2014 Nov;63(11):1700-10. doi: 10.1136/gutjnl-2013-305806. Epub 2014 Feb 12.

13.

A potential signature of eight long non-coding RNAs predicts survival in patients with non-small cell lung cancer.

Zhou M, Guo M, He D, Wang X, Cui Y, Yang H, Hao D, Sun J.

J Transl Med. 2015 Jul 17;13:231. doi: 10.1186/s12967-015-0556-3.

14.

Construction and validation of a seven-microRNA signature as a prognostic tool for lung squamous cell carcinoma.

Gan Z, Zou Q, Lin Y, Huang X, Huang Z, Chen Z, Xu Z, Lv Y.

Cancer Manag Res. 2019 Jun 21;11:5701-5709. doi: 10.2147/CMAR.S191637. eCollection 2019.

15.

Development of a novel prognostic signature of long non-coding RNAs in lung adenocarcinoma.

Zheng S, Zheng D, Dong C, Jiang J, Xie J, Sun Y, Chen H.

J Cancer Res Clin Oncol. 2017 Sep;143(9):1649-1657. doi: 10.1007/s00432-017-2411-9. Epub 2017 Apr 13.

PMID:
28409273
16.

Identification of a multidimensional transcriptome signature for survival prediction of postoperative glioblastoma multiforme patients.

Gao WZ, Guo LM, Xu TQ, Yin YH, Jia F.

J Transl Med. 2018 Dec 20;16(1):368. doi: 10.1186/s12967-018-1744-8.

17.

Discovery of a novel six-long non-coding RNA signature predicting survival of colorectal cancer patients.

Fan Q, Liu B.

J Cell Biochem. 2018 Apr;119(4):3574-3585. doi: 10.1002/jcb.26548. Epub 2018 Jan 15.

PMID:
29227531
18.

A ten-long non-coding RNA signature for predicting prognosis of patients with cervical cancer.

Shen L, Yu H, Liu M, Wei D, Liu W, Li C, Chang Q.

Onco Targets Ther. 2018 Sep 28;11:6317-6326. doi: 10.2147/OTT.S175057. eCollection 2018.

19.

A 15-long non-coding RNA signature to improve prognosis prediction of cervical squamous cell carcinoma.

Mao X, Qin X, Li L, Zhou J, Zhou M, Li X, Xu Y, Yuan L, Liu QN, Xing H.

Gynecol Oncol. 2018 Apr;149(1):181-187. doi: 10.1016/j.ygyno.2017.12.011. Epub 2018 Mar 8.

PMID:
29525275
20.

A five-long non-coding RNA signature to improve prognosis prediction of clear cell renal cell carcinoma.

Shi D, Qu Q, Chang Q, Wang Y, Gui Y, Dong D.

Oncotarget. 2017 Apr 28;8(35):58699-58708. doi: 10.18632/oncotarget.17506. eCollection 2017 Aug 29.

Supplemental Content

Support Center